Close it

Would you like to become a TBEC member? Please fill out the form below.

By becoming a TBEC member, you agree to endorse the values and the principles of the TB Europe Coalition, and agree with its membership rights and responsibilities.

Membership is free of charge.

TBEC membership rights

TBEC membership responsibilities











Posts tagged "DR TB"

Regional Meeting on Civil Society Capacity Building for DR-TB treatment in EECA

TB Europe Coalition (TBEC) is organising a  regional meeting on capacity building of civil society to advocate for safe and affordable drug-resistant TB (DR-TB) treatment in the region of Eastern Europe and Central Asia. This will take place from 18th-20th June 2019 in Kiev, Ukraine. We particularly welcome applications from representatives of patient groups, organizations working with vulnerable groups of people living with TB or TB/HIV, as and representatives of civil society organizations which advocate for access to TB/HIV treatment. The deadline for submissions has passed. Meeting Objectives: Increase understanding of the principles of the new WHO guidelines on DR-TB for achieving quality people-centered and rights-based TB care; Map barriers to the launch of the new WHO DR-TB guidelines in different countries and define the role of civil society in overcoming these barriers; Define ways for civil society actions to build demand among people undergoing TB treatment for the use of the new and safe medicines; Increase understanding of the role of informed consent in relation to treatment options as a human-rights based tool and to support civil society to improve practices of informed consent in their home countries and manage ethical considerations. Increase understanding of tools for monitoring of side More…

Drug resistant tuberculosis a cross border threat: EU must act now!

Drug resistant tuberculosis a cross border threat: EU must act now!

  The TB Europe Coalition released a call to action urging the European Union to take immediate action against drug resistant tuberculosis, which is a serious cross-border health threat. With an estimated 74,000 cases of multi-drug resistant TB (MDR-TB) in 2012, the European region carries nearly a quarter of the global burden of drug-resistant cases and hosts 15 of the 27 high MDR-TB burden countries in the world, five of them being EU Member states. Many governments in the region often do not have the resources or the political will to adequately fight TB and are often dependent on external support to finance their TB programmes. However, the largest international donor for TB programmes, the Global Fund to Fight AIDS, TB and Malaria, is phasing out its support to the region, leaving an important financial vacuum. If European countries do not immediately step up their response we will be faced with an increased risk of MDR-TB spreading throughout the region on an even greater scale. Particularly concerning are the increasing rates of drug resistance among new TB cases and the low treatment success rates of the region: some of the most worrying in the world. According to a recent study, TB costs the More…

EXPOSED: The Global Epidemic

EXPOSED: The Global Epidemic

This week, Aeras, an organisation dedicated to the development of effective tuberculosis (TB) vaccines, launched the first film – The Global Epidemic – in a series of shorts that tells the story of the deadly global epidemic of TB. The films are told through the eyes of TB patients, physicians, scientists, advocates and policymakers, thus making for particularly powerful viewing. Every year, approximately nine million men, women and children across the world become sick with TB, and 1.4 million die. This is a problem not just isolated to developing countries. As we frequently mention in our blogposts, TB remains a considerable problem in the region, particularly worrying are the increasing numbers of MDR-TB. Europe hosts some of the worst rates of the strain in the world. An estimated 76,000 MDR-TB cases occurred in the WHO European Region in 2011, accounting for nearly 25 percent of cases worldwide. The film covers the story of Natalie Skipper, an MDR-TB survivor, who explains how difficult MDR-TB is to treat both in terms of cost and in the devastating side-effects it has on patients and their loved ones. It also makes the important point that TB is a disease that does not respect borders or target More…

Azerbaijan achieves some of the best cure rates for drug-resistant TB in prisons

Azerbaijan achieves some of the best cure rates for drug-resistant TB in prisons

A new film produced for the International Committee of the Red Cross shows how Azerbaijan has managed to achieve some of the best cure rates for multi-drug resistant TB (MDR-TB) in prisons in the former Soviet Union and one of the best worldwide. The European region hosts some of the worst rates of MDR-TB in the world, particularly in countries formerly part of the Soviet Union. This is largely as a result of a disintegration of effective healthcare after the deterioration of the USSR. This meant that TB either went untreated or was treated improperly meaning that drug-resistant strains were able to emerge. The treatment of these strains remains a considerable problem in the region and in places of detention the issue is even worse. However, there is hope that the problem is being beginning to be addressed with Azerbaijan an example of what can be achieved with the correct focus. The ICRC explain that the film shows how a combination of individual attention at the country’s central treatment facility, specialist follow-up care and solid political commitment, has made Azerbaijan a model for combating MDR-TB in prisons. The WHO has recognised that Azerbaijan’s programme is a model to learn from and has taken delegations More…

Comprehensive report on drug-resistant tuberculosis launches in the UK

Comprehensive report on drug-resistant tuberculosis launches in the UK

This week, the All Party Parliamentary Group on Global Tuberculosis (UK) launched a report – Drug-Resistant Tuberculosis: Old Disease, New Threat – highlighting the increasing concern that exists about growing rates of drug-resistant TB (DR-TB). The comprehensive piece was compiled after considerable time spent on processing both written and oral evidence from a number of experts in the field.The report identifies the main challenges facing not only the UK but also the world and outlines a series of recommendations for swift action where the biggest impact can be made. Importantly, the report highlights that it is not only developing countries that are witnessing a rise in DR-TB. Significantly, it makes note of the fact that 15 of the 27 highest burden countries are in the WHO European region. Almost 80,000 multi-drug resistant TB (MDR-TB) cases occurred in the region in 2011, accounting for nearly a quarter of all MDR-TB cases worldwide. In Russia, Belarus and Ukraine between nine to 32% of new cases and more than 50% of previously treated cases have MDR-TB. These figures should drive our leaders both domestically and at an EU level to take action. Not only are DR-TB strains more difficult to treat but they More…

We Can Heal: Drug-resistant tuberculosis in children

We Can Heal: Drug-resistant tuberculosis in children

To mark World TB Day 2013, the Sentinel Project on Paediatric Drug-Resistant Tuberculosis and Treatment Action Group released a collection of 30 stories from 30 countries that identify what the TB community needs to do to achieve zero TB deaths, new infections, and suffering. As the release states, the collection of stories illustrate the problems we collectively face with drug-resistant TB (DR-TB) in children. The stories reveal the widespread problems of prevention, diagnosis, and treatment of DR-TB while also bearing witness to the courage of the children who are fighting for their lives against DR-TB. Over the past 10 years, 40,000 cases of childhood TB were reported in the EU alone, indicating that TB in children remains a major challenge even with the European Region. A selection of the stories in the publication reflect this trend with stories from Moldova, Italy, Sweden, Belgium. All of the stories in this collection, both from within the EU and further afield, are testament to the work that remains to be done in ensuring that TB is eradicated once and for all and making sure that children across the world are able to live the carefree lives they deserve. Currently, children are going undiagnosed More…

World Health Organisation and Global Fund stress need for increased funding to prevent spread of TB

World Health Organisation and Global Fund stress need for increased funding to prevent spread of TB

On the occasion of World TB Day, 24th March 2013, the World Health Organisation (WHO) and the Global Fund to Fight AIDS, TB and Malaria have called for US$1.6 billion a year in international financing to prevent the spread of tuberculosis.  Here is their joint press release:  18 MARCH 2013 | GENEVA – WHO and the Global Fund to Fight AIDS, TB and Malaria said today that strains of tuberculosis with resistance to multiple drugs could spread widely and highlight an annual need of at least US$ 1.6 billion in international funding for treatment and prevention of the disease. Dr Margaret Chan, Director-General of WHO, and Dr Mark Dybul, Executive Director of the Global Fund, said that the only way to carry out the urgent work of identifying all new cases of tuberculosis, while simultaneously making progress against the most serious existing cases, will be to mobilize significant funding from domestic sources and international donors. “We are treading water at a time when we desperately need to scale up our response to MDR-TB” WHO Director-General Dr Margaret Chan With the overwhelming majority of international funding for tuberculosis coming through the Global Fund, they said, it is imperative that efforts to raise money More…

New European Committee on DR-TB appoints TB Europe Coalition as Chair

New European Committee on DR-TB appoints TB Europe Coalition as Chair

On 4 December, the first meeting of the Regional Interagency Collaborative Committee on TB care and control (RICC-TB) took place in Copenhagen. The TB Europe Coalition had been pushing for the creation of this oversight mechanism for the past few years to make sure a stronger commitment be made in the fight against drug-resistant TB in the European region.   Rates of drug-resistant TB in the European region are among the highest in the world. The region bears 20% of the global burden and gathers 18 out of the 27 high-burden DR-TB countries worldwide. DR-TB treatment success rate are higher in the Democratic Republic of Congo (50%) than in Romania (20%), which – let’s not forget – is an European Union member state. This is unacceptable. Also, in the global discussion on TB, the European region is rarely at the centre of attention. Only last month at the World Conference on Lung Health (the Union meeting in Malaysia), I didnt come across any civil society activist from the European region! TB and global health activists from Africa were quite numerous in contrast. This definitely shows a great imbalance. Time has come to act! RICC-TB is a unique platform that gathers More…

New report: An Evaluation of Drug-Resistant TB Scale-Up

This report, written by Médecins Sans Frontières (MSF), Partners In Health (PIH), and the Treatment Action Group (TAG) – organisations involved in efforts to increase access to treatment and care for patients with DR-TB – aims to provide an assessment of the effectiveness of some key structures within the global response for MDR-TB, to provide recommendations on how the global response to DR-TB scale-up can be improved, and to examine the results of scale-up activities to date in three key countries. It is meant to be a first step towards greater accountability from countries, international mechanisms and donors, all of whom must work collaboratively to address the substantial barriers to scaling-up MDR-TB treatment. Currently, the GLC and GDF are being reformed to address some of the challenges highlighted in this report. It is hoped that this report will constructively inform the debate about how best to foster the scale-up of DR-TB treatment and prevention. Download the full report through the link below: http://www.msfaccess.org/resources/key-publications/key-publication-detail/?tx_ttnews[tt_news]=1701&cHash=4fbe2e1d99

wink.pink